Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

What company makes Tylenol? Kimberly-Clark buys Kenvue in massive billion-dollar deal. Here's the who and what to know about other brands they own.

Kimberly-Clark, maker of Cottonelle and Scott toilet paper, Huggies and Kleenex tissues is buying Kenvue.  The purchase adds ...

Kenvue offers stable financials, a robust 5% dividend yield, and the stock trades at a significant discount to peers and historical averages. KVUE's recent decline, driven by Tylenol-related headlines ...

Shares of Kenvue fell 13% Thursday to $14.11, its lowest finish since the consumer healthcare firm spun off from Johnson & Johnson in 2023. The decline was the sharpest on record for Kenvue, according ...

Kenvue Inc. (NYSE:KVUE) is in a partnership with AI company Albert Invent to accelerate end-to-end R&D efforts across the company’s global portfolio of brands. The partnership is expected to enable ...

The consumer healthcare specialist has inherited a long-running legal controversy. It is facing its first lawsuit in the U.K. centered on a controversial product. The first such lawsuit in the U.K.

Kenvue urged the Food and Drug Administration to deny a proposal to add further warnings to acetaminophen products after the Trump Administration linked Tylenol use during pregnancy to autism. The ...

The consumer healthcare specialist has inherited a long-running legal controversy. It is facing its first lawsuit in the U.K. centered on a controversial product. Until it was spun off into a separate ...

(Reuters) -Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain medication Tylenol for use during pregnancy, after President Donald ...

Kenvue faces investor pressure amid strategic review, leadership changes and litigation risk Trump administration position on Tylenol erased $10 billion in market value Potential sale or spin-off of ...